Key result
Pericardial biopsy reveals tuberculous pericarditis in unexplained recurrent effusion, guiding successful anti-tuberculosis therapy.
Why the study?
In patients with atypical clinical presentation, tuberculous pericarditis can lead to misdiagnosis, missed diagnosis, and delayed treatment.
Case Report (n=1)
No
In cases of unexplained pericardial effusion, negative laboratory tests cannot exclude tuberculosis, and pericardial biopsy with empirical antituberculosis therapy may be necessary in high-burden regions.
Negative fluid tests do not exclude tuberculous pericarditis; this case leaves open whether biopsy should guide therapy in unexplained effusions.
Tuberculosis is a main cause of pericardial disease in developing countries. However, in patients with atypical clinical presentation, it can lead to misdiagnosis, missed diagnosis, and delayed treatment. In this study, we report a case of a 61-year-old woman admitted to the cardiac intensive care unit with "weakness and loss of appetite" and a large pericardial effusion shown by echocardiography. After hospitalization, a pericardiocentesis was performed, and the pericardial fluid was hemorrhagic. However, the Xpert MTB/RIF and T-SPOT tests were negative, and repeated phlegm antacid smears and culture of pericardial fluid did not reveal antacid bacilli. The patient eventually underwent thoracoscopic pericardial biopsy, which revealed extensive inflammatory cells and significant granulomas. Combined with the fact that the patient's pericardial effusion was exudate, the patient was considered to be suspected of tuberculous pericarditis (TBP) and given empirical anti-tuberculosis treatment the patient's symptoms improved and the final diagnosis was TBP. In this case report, it is further shown that a negative laboratory test cannot exclude tuberculosis infection. In recurrent unexplained pericardial effusions, the pericardial biopsy is feasible. In countries with a high burden of tuberculosis, empirical antituberculosis therapy may be used to treat the pericardial effusion that excludes other possible factors.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2022) conducted a case report in Tuberculous pericarditis (n=1). Anti-tuberculosis treatment and prednisolone was evaluated on Symptom improvement. A 61-year-old woman with recurrent unexplained pericardial effusion and negative laboratory tests was successfully diagnosed with tuberculous pericarditis via pericardial biopsy and improved with anti-tuberculosis therapy.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: